ISPOR Europe 2026
Workshop Expanded Value Measures track
Integrating Patient, Payer, and Investor Perspectives on Valuing Innovative Medicines for Orphan Diseases
Sun, Nov 8, 2026 · 1:00–5:00 PM CET Hall N2, Level 1, Austria Center Vienna
About this session
Separate registration required. Explore the value assessment of innovative drugs from the perspectives of relevant stakeholders, their respective data requirements, and their methods and processes. Gain a better understanding of the value assessment from the investor perspective, with a focus on orphan drugs and advanced therapy medical products (ATMPs).
